Ignite Creation Date:
2024-05-06 @ 8:34 AM
Last Modification Date:
2024-10-26 @ 12:02 PM
Study NCT ID:
NCT02767661
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-16
First Post:
2016-05-07
Brief Title:
Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR Her2- Metastatic Breast Cancer
Sponsor:
Organization:
Sun Yat-sen University